ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 112 filers reported holding ACLARIS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,052,842 | -69.6% | 299,685 | -54.0% | 0.02% | -73.3% |
| Q2 2023 | $6,750,113 | +36.0% | 650,927 | +6.1% | 0.09% | +30.4% |
| Q1 2023 | $4,962,827 | -22.3% | 613,452 | +51.3% | 0.07% | -31.0% |
| Q4 2022 | $6,387,696 | +8.8% | 405,568 | -45.6% | 0.10% | +51.5% |
| Q3 2022 | $5,868,863 | +25.6% | 745,014 | +122.6% | 0.07% | -28.3% |
| Q2 2022 | $4,672,000 | +6.1% | 334,666 | +31.0% | 0.09% | +73.6% |
| Q1 2022 | $4,404,000 | +69.8% | 255,478 | +43.3% | 0.05% | +178.9% |
| Q4 2021 | $2,593,000 | +305.2% | 178,310 | +80.4% | 0.02% | +216.7% |
| Q4 2020 | $640,000 | +509.5% | 98,845 | +52.1% | 0.01% | +100.0% |
| Q2 2020 | $105,000 | – | 65,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |